Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone for luteal support in IVF: a multicenter prospective real-world observational study
CTR20220657Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dydrogesterone in infertility, luteal insufficiency, sponsored by Abbott Laboratories. Started Jul 2022; status: completed.
02
Drugs
dydrogesterone
03
Conditions
infertilityluteal insufficiency
Beyond the preview
Go deeper on CTR20220657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220657.